206 related articles for article (PubMed ID: 10647878)
41. The impact of stage and treatment modality on the likelihood of second malignancies and hematopoietic disorders in Hodgkin's disease.
Mendenhall NP; Shuster JJ; Million RR
Radiother Oncol; 1989 Mar; 14(3):219-29. PubMed ID: 2710953
[TBL] [Abstract][Full Text] [Related]
42. Long-term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma.
Bokemeyer C; Schmoll HJ; van Rhee J; Kuczyk M; Schuppert F; Poliwoda H
Ann Hematol; 1994 Mar; 68(3):105-10. PubMed ID: 8167175
[TBL] [Abstract][Full Text] [Related]
43. Increased mortality after successful treatment for Hodgkin's disease.
Hudson MM; Poquette CA; Lee J; Greenwald CA; Shah A; Luo X; Thompson EI; Wilimas JA; Kun LE; Crist WM
J Clin Oncol; 1998 Nov; 16(11):3592-600. PubMed ID: 9817280
[TBL] [Abstract][Full Text] [Related]
44. Breast cancer after treatment of Hodgkin's disease.
Hancock SL; Tucker MA; Hoppe RT
J Natl Cancer Inst; 1993 Jan; 85(1):25-31. PubMed ID: 8416252
[TBL] [Abstract][Full Text] [Related]
45. [Secondary non-Hodgkin's lymphomas].
Cappelaere P
Bull Cancer; 1998 Mar; 85(3):217-31. PubMed ID: 9752310
[TBL] [Abstract][Full Text] [Related]
46. Second cancer among long-term survivors from Hodgkin's disease.
Nyandoto P; Muhonen T; Joensuu H
Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):373-8. PubMed ID: 9788418
[TBL] [Abstract][Full Text] [Related]
47. Second malignant neoplasms in patients with Hodgkin's disease.
Robinson BA; Colls BM; Fitzharris BM; Atkinson CH
Aust N Z J Med; 1994 Aug; 24(4):368-73. PubMed ID: 7980232
[TBL] [Abstract][Full Text] [Related]
48. Second solid tumors and leukemia after treatment for Hodgkin's disease: an analysis of 1121 patients from a single institution.
Biti G; Cellai E; Magrini SM; Papi MG; Ponticelli P; Boddi V
Int J Radiat Oncol Biol Phys; 1994 Apr; 29(1):25-31. PubMed ID: 8175441
[TBL] [Abstract][Full Text] [Related]
49. Solid tumors in patients treated for Hodgkin's disease: a report from the German Hodgkin Lymphoma Study Group.
Behringer K; Josting A; Schiller P; Eich HT; Bredenfeld H; Diehl V; Engert A;
Ann Oncol; 2004 Jul; 15(7):1079-85. PubMed ID: 15205202
[TBL] [Abstract][Full Text] [Related]
50. Long-term outcome of treatment for Ann Arbor stage 1 Hodgkin's disease: patterns of failure, late toxicity and second malignancies.
Vlachaki MT; Ha CS; Hagemeister FB; Fuller LM; Rodriguez MA; Besa PC; Hess MA; Brown B; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):609-16. PubMed ID: 9336140
[TBL] [Abstract][Full Text] [Related]
51. Second malignancies after childhood Hodgkin's disease. The Memorial Sloan-Kettering Cancer Center experience.
Kushner BH; Zauber A; Tan CT
Cancer; 1988 Oct; 62(7):1364-70. PubMed ID: 3046737
[TBL] [Abstract][Full Text] [Related]
52. [Hodgkin's lymphoma and secondary leukemias].
Centurioni R; Brianzoni MF; Salvi A; Montillo M; Rupoli S; Olivieri A; Leoni P; Danieli G
Recenti Prog Med; 1993 May; 84(5):328-35. PubMed ID: 8511392
[TBL] [Abstract][Full Text] [Related]
53. Pediatric Hodgkin's disease: treatment in the late 1990s.
Schellong G
Ann Oncol; 1998; 9 Suppl 5():S115-9. PubMed ID: 9926249
[TBL] [Abstract][Full Text] [Related]
54. Breast cancer in Hodgkin's disease and non-Hodgkin's lymphoma survivors.
Sanna G; Lorizzo K; Rotmensz N; Bagnardi V; Cinieri S; Colleoni M; Nolè F; Goldhirsch A
Ann Oncol; 2007 Feb; 18(2):288-92. PubMed ID: 17088328
[TBL] [Abstract][Full Text] [Related]
55. Long-term survival in Hodgkin's disease relative impact of mortality, second tumors, infection, and cardiovascular disease.
Mauch PM; Kalish LA; Marcus KC; Shulman LN; Krill E; Tarbell NJ; Silver B; Weinstein H; Come S; Canellos GP; Coleman CN
Cancer J Sci Am; 1995; 1(1):33-42. PubMed ID: 9166452
[TBL] [Abstract][Full Text] [Related]
56. Second primary cancer following Hodgkin's disease: updated results of an Italian multicentric study.
Cimino G; Papa G; Tura S; Mazza P; Rossi Ferrini PL; Bosi A; Amadori S; Lo Coco F; D'Arcangelo E; Giannarelli D
J Clin Oncol; 1991 Mar; 9(3):432-7. PubMed ID: 1999712
[TBL] [Abstract][Full Text] [Related]
57. The risk of non-Hodgkin's lymphoma after Hodgkin's disease, with special reference to splenic treatment.
Enrici RM; Anselmo AP; Iacari V; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1998 Jul; 83(7):636-44. PubMed ID: 9718869
[TBL] [Abstract][Full Text] [Related]
58. Reduced incidence of second solid tumors in survivors of childhood Hodgkin's lymphoma treated without radiation therapy.
Barbaro PM; Johnston K; Dalla-Pozza L; Cohn RJ; Wang YA; Marshall GM; Ziegler DS
Ann Oncol; 2011 Dec; 22(12):2569-2574. PubMed ID: 21393381
[TBL] [Abstract][Full Text] [Related]
59. Analysis of in-field control and late toxicity for adults with early-stage Hodgkin's disease treated with chemotherapy followed by radiotherapy.
Chronowski GM; Wilder RB; Tucker SL; Ha CS; Younes A; Fayad L; Rodriguez MA; Hagemeister FB; Barista I; Cabanillas F; Cox JD
Int J Radiat Oncol Biol Phys; 2003 Jan; 55(1):36-43. PubMed ID: 12504034
[TBL] [Abstract][Full Text] [Related]
60. Long-term follow-up of patients treated with primary radiotherapy for supradiaphragmatic Hodgkin's disease at St. Jude Children's Research Hospital.
Shah AB; Hudson MM; Poquette CA; Luo X; Wilimas JA; Kun LE
Int J Radiat Oncol Biol Phys; 1999 Jul; 44(4):867-77. PubMed ID: 10386644
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]